Search

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.

What does the future hold for lipid nanoparticles?

Fake tweet announcing free insulin leads to mayhem.

Historic challenges in ADC Development have not thwarted some players

The evaluation of nitrosamines in drug products has become a big challenge for many formulators in the pharmaceutical industry.

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

How a new working group plans to overcome the problem with in vitro pharmacology data.

Unregulated drugs being sold and distributed by the online retailer come under fire.

Old photos, newspaper clippings, and more tell the origin story of a major product line

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world